Ⅵ 부록
1. 소위원회
프로게스테론 수용체검사[EIA] 소위원회는 신의료기술평가 전문평가위원회 명단에서 무작위로 선정한 전문가와 해당 학회에서 추천을 받은 전문가로 구성하였으며, 최종 8인 (병리과 3인, 외과 3인, 혈액종양내과 1인, 근거중심의학 1인)으로 구성되었다.
1.1. 제1차 소위원회
▪ 회의일시: 2019년 5월 7일 18:00
▪ 회의내용: 행위정의, 평가계획서 논의
1.2. 이후 소위원회
▪ 2차 소위원회는 개최하지 않았으며, 최종 작성된 보고서에 대한 서면검토로 대체
프로게스테론 수용체검사 [EIA]의 안전성 및 유효성 평가
32
2. 문헌 검색 전략
2.1. 국외 데이터베이스
2.1.1. Ovid MEDLINE(R) and In-Process & Other Non-Indexed Citations 1946 to May 01, 2019 <검색일: 2019. 5. 2.>
구분 No. Searches MEDLINE
Patients
1 exp Breast Neoplasms/ 275,112
2 breast cancer.mp. 244,925
3 1 or 2 339,158
Index test
4 exp Immunoenzyme Techniques/ 210,109
5 enzyme immunoassay.mp. 19,467
6 EIA.mp 9549
7 4 or 5 or 6 222,473
8 exp Receptors, Estrogen/ or estrogen receptor*.mp. 69,779 9 exp Receptors, Progesterone/ or progesteron receptor*.mp. 18,443
10 8 or 9 74,669
1 exp breast cancer/ 427,978
2 breast cancer.mp. 463,254
3 1 or 2 507,882
Index test
4 exp enzyme immunoassay/ 41,616
5 enzyme immunoassay.mp. 50,101
6 EIA.mp. 13,432
7 4 or 5 or 6 54,761
8 exp estrogen receptor/ or estrogen receptor*.mp. 106,512 9 exp progesterone receptor/ or progesteron receptor*.mp. 36,109
10 8 or 9 115,180
P&I 11 3 and 7 and 10 467
12 limit 10 to humans 451
13 limit 12 to english language 417
Ⅵ. 부록
3. 선택된 문헌
Cavaliere AB, E.Sidoni, A.Bianchi, G.Pietropaoli, N.Ludovini, V.Vitali, R. Estrogen and progesterone receptors in breast cancer: comparison between enzyme immunoassay and computer-assisted image analysis of immunocytochemical assay. Cytometry. 1996;26(3):204-8.
Cerra M, Cecco L, Montella M, Celentano E, Bonelli P, Tuccillo F. Determination of estrogen and progesterone receptors in human breast cancer cytosols: a comparison between radioligand binding assay (DCC) and enzyme immunoassay (EIA). Int J Biol Markers. 1996 Jan-Mar;11(1):50-2.
Ferno MB, A.Sellberg, G. Enzyme immuno assay of the estrogen receptor in breast cancer biopsy samples. A comparison with isoelectric focusing. Acta Radiologica - Oncology. 1986;25(3):171-5.
Fiets WE, Blankenstein MA, Struikmans H, Ruitenberg HM, Nortier JWR. The prognostic value of hormone receptor detection by enzyme immunoassay and immunohistochemistry: A prospective study in patients with early breast cancer.
International Journal of Biological Markers. 2002;17(1):24-32.]
Foekens JA, Portengen H, van Driel J, van Putten WL, Haije WG, Klijn JG.
Comparison of enzyme immunoassay and dextran-coated charcoal techniques for progesterone receptor determination in human breast cancer cytosols. J Steroid Biochem. 1988 Jun;29(6):571-4.
Foekens JA, Portengen H, van Putten WL, Peters HA, Krijnen HL, Alexieva-Figusch J, Klijn JG. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Cancer Res. 1989 Nov 1;49(21):5823-8.
Gion MD, R.Leon, A. E.Bruscagnin, G.Pelizzola, D.Giovannini, G.Giganti, M.Messeri, G.Quercioli, M.Flamini, E.et al.,. Comparison between single saturating dose ligand binding assay and enzyme immunoassay for low-salt extractable oestrogen and progesterone receptors in breast cancer: a multicentre study.
European Journal of Cancer. 1991;27(8):996-1002.
Holmes FAF, H. A.Loewy, J. W.Geitner, A. M.Sutton, R. C.Buzdar, A. U.Hortobagyi, G.
N. Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay. Journal of Clinical Oncology. 1990;8(6):1025-35.
Jarque FL, A.Vizcarra, E.Munoz, M.Alberola, V.Garcia-Conde, J. Quantitative monoclonal antibody determination of estrogen and progesterone receptors in human breast cancer: correlation with the radioligand method. Oncology.
1994;51(5):435-9.
Marsigliante SP, J. R.Barker, S.Gledhill, J.Vinson, G. P. Discrepancies between antibody (EIA) and saturation analysis of oestrogen receptor content in breast tumour samples. Journal of Steroid Biochemistry & Molecular Biology.
1990;37(5):643-8.
프로게스테론 수용체검사 [EIA]의 안전성 및 유효성 평가
34
Mink DH, M.von Tongelen, B.Villena-Heinsen, C.Schmidt, W. Demonstration of estrogen and progesterone receptors in breast cancers with monoclonal antibodies. Different results with enzyme-immunoassay and immunohistochemical methods. European Journal of Gynaecological Oncology.
1995;16(2):81-91.
Nishimura RS, T.Ohsumi, S.Tani, Y.Takashima, S. Immunohistochemical expression of hormone receptors and the histological characteristics of biochemically hormone receptor negative breast cancers. Breast Cancer. 2007;14(1):100-4.
Noguchi S, Miyauchi K, Imaoka S, Koyama H, Iwanaga T. Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols. Eur J Cancer Clin Oncol. 1988 Nov;24(11):1715-9.
Ogawa YM, T.Kato, Y.Oguma, M.Ikeda, K.Takashima, T.Nakata, B.Ishikawa, T.Hirakawa, K. Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: analysis for a cut-off point as the predictor for endocrine therapy. Breast Cancer. 2004;11(3):267-75.
Piffanelli AG, G.Pelizzola, D.De Bortoli, M.Catozzi, L.Giganti, M. Steroid receptor assays: an Italian quality assessment program. Annali Dell'Istituto Superiore di Sanita. 1991;27(3):523-9.
Romain SLB, C.Martin, P. M.Magdelenat, H. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group. European Journal of Cancer. 1995;31A(3):411-7.
Wittliff JL, Miseljic S, Cummins JA, Pasic R. Does menopausal status influence sex-steroid receptor content and specific-binding capacity? Journal of Clinical Ligand Assay. 1996;19(3):203-7.
Wu JT, Wilson LW. Progesterone receptor: stability studies and correlation between steroid binding assay and enzyme immunoassay. Clin Chem. 1988 Oct;34(10):1987-91.
Zafrani BA, M. H.Mouret, E.De Cremoux, P.De Rycke, Y.Nicolas, A.Boudou, E.Vincent-Salomon, A.Magdelenat, H.Sastre-Garau, X. High sensitivity and specificity of immunohistochemistry for the detection of hormone receptors in breast carcinoma: comparison with biochemical determination in a prospective study of 793 cases. Histopathology. 2000;37(6):536-45.
발행일 2020. 03. 31.
발행인 한 광 협
발행처 한국보건의료연구원
이 책은 한국보건의료연구원에 소유권이 있습니다.
한국보건의료연구원의 승인 없이 상업적인 목적으로 사용하거나 판매할 수 없습니다.
ISBN : 978-89-6834-627-9
의료기술재평가보고서 2019